Efficacy and Safety of Enhanced Recovery After Surgery (ERAS) Protocols for Patients Undergoing Minimally Invasive Transforaminal Lumbar Interbody Fusion Surgery: A Systematic Review and Meta-Analysis
- PMID: 38810875
- DOI: 10.1016/j.wneu.2024.05.133
Efficacy and Safety of Enhanced Recovery After Surgery (ERAS) Protocols for Patients Undergoing Minimally Invasive Transforaminal Lumbar Interbody Fusion Surgery: A Systematic Review and Meta-Analysis
Abstract
Objective: To evaluate the efficacy and safety of enhanced recovery after surgery (ERAS) in minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) for lumbar degenerative disease (LDD).
Methods: Electronic databases including PubMed, Embase, the Cochrane Library, Web of Science, Clinical Trials.gov, etc. were searched from inception to October 2023. Randomized controlled trials (RCTs) and cohort studies (CSs) comparing ERAS program with traditional protocol of MIS-TLIF for LDD were included.
Results: A total of 11 studies were included for final analysis. The pooled results of RCTs showed that compared with MIS-TLIF, the ERAS program used in MIS-TLIF could reduce the length of hospital stay, operation time, intraoperative blood loss and incidence of postoperative complications, decrease visual analog scale and Oswestry Disability Index (ODI) score, and improve patient satisfaction (P < 0.05). However, the pooled results of CSs revealed no statistical difference in the ODI score, fusion rate, operation time, and incidence of complications between the two groups (P > 0.05).
Conclusions: Compared with MIS-TLIF, the ERAS program used in MIS-TLIF could effectively shorten the length of hospital stay, operation time, decrease intraoperative blood loss, and incidence of postoperative complications, promote postoperative pain relief, functional recovery, and patient satisfaction. This study confirmed the value of ERAS in MIS-TLIF surgery and provided evidence for the standardization of ERAS in the future. Considering that the pooled results of RCTs and CSs are not completely consistent, more high-quality studies are needed to confirm these conclusions.
Keywords: Enhanced recovery after surgery; Lumbar degenerative disease; Meta-analysis; Minimally invasive transforaminal lumbar interbody fusion; Systematic review.
Copyright © 2024. Published by Elsevier Inc.
Similar articles
-
Meta-analysis of minimally invasive transforaminal lumbar interbody fusion versus oblique lumbar interbody fusion for treating lumbar degenerative diseases.J Orthop Surg Res. 2024 Dec 30;19(1):891. doi: 10.1186/s13018-024-05422-3. J Orthop Surg Res. 2024. PMID: 39736715 Free PMC article.
-
Unilateral biportal endoscopic lumbar interbody fusion versus minimally invasive transforaminal lumbar interbody fusion for single-segment lumbar degenerative disease: a meta-analysis.BMC Musculoskelet Disord. 2024 Nov 21;25(1):938. doi: 10.1186/s12891-024-08046-0. BMC Musculoskelet Disord. 2024. PMID: 39574056 Free PMC article.
-
Endoscopic Lumbar Interbody Fusion and Minimally Invasive Transforaminal Lumbar Interbody Fusion for the Treatment of Lumbar Degenerative Diseases: A Systematic Review and Meta-Analysis.World Neurosurg. 2021 Aug;152:e352-e368. doi: 10.1016/j.wneu.2021.05.109. Epub 2021 Jun 1. World Neurosurg. 2021. PMID: 34087465
-
Clinical outcomes after minimally invasive transforaminal lumbar interbody fusion and lateral lumbar interbody fusion for treatment of degenerative lumbar disease: a systematic review and meta-analysis.Neurosurg Rev. 2018 Jul;41(3):755-770. doi: 10.1007/s10143-016-0806-8. Epub 2016 Dec 24. Neurosurg Rev. 2018. PMID: 28013419
-
Comparing the efficacy of unilateral biportal endoscopic transforaminal lumbar interbody fusion and minimally invasive transforaminal lumbar interbody fusion in lumbar degenerative diseases: a systematic review and meta-analysis.J Orthop Surg Res. 2023 Nov 22;18(1):888. doi: 10.1186/s13018-023-04393-1. J Orthop Surg Res. 2023. PMID: 37993948 Free PMC article.
Cited by
-
Comparison of short-term effectiveness between unilateral biportal endoscopic and MED-assisted transforaminal lumbar interbody fusion for mild single-segment lumbar spondylolisthesis.BMC Musculoskelet Disord. 2025 Jul 4;26(1):631. doi: 10.1186/s12891-025-08892-6. BMC Musculoskelet Disord. 2025. PMID: 40615825 Free PMC article.
-
Comparison of the short-term efficacy of MIS-TLIF and Endo-LIF for the treatment of two-segment lumbar degenerative disease.BMC Musculoskelet Disord. 2024 Sep 4;25(1):708. doi: 10.1186/s12891-024-07815-1. BMC Musculoskelet Disord. 2024. PMID: 39232720 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources